Sulphonylurea failure in type 2 diabetes: treatment with a basal insulin supplement.
Many diabetic patients continue to have hyperglycaemia on maximal sulphonylurea therapy. Five different therapeutic options, with the prime aim of achieving normal fasting plasma glucose concentrations, have been compared in 15 asymptomatic, sulphonylurea-treated type 2 diabetic patients in a random...
Principais autores: | Holman, R, Steemson, J, Turner, R |
---|---|
Formato: | Journal article |
Idioma: | English |
Publicado em: |
1987
|
Registros relacionados
-
TWICE-DAILY SUBCUTANEOUS HUMAN PROINSULIN PROVIDES A SATISFACTORY BASAL INSULIN SUPPLEMENT IN TYPE-2 (NON-INSULIN-DEPENDENT) DIABETIC-PATIENTS
por: Holman, R, et al.
Publicado em: (1987) -
Post-prandial amylin concentrations are increased by sulphonylurea, but unchanged by basal insulin, in NIDDM
por: Rachman, J, et al.
Publicado em: (1996) -
UKPDS 26: Sulphonylurea failure in non-insulin-dependent diabetic patients over six years
por: Matthews, DR, et al.
Publicado em: (1998) -
UKPDS 18: Estimated dietary intake in type 2 diabetic patients randomly allocated to diet, sulphonylurea or insulin therapy
por: Eeley, E, et al.
Publicado em: (1996) -
COMPARISON OF TREATMENT OF MILD DIABETES WITH A BASAL INSULIN SUPPLEMENT OR SULFONYLUREA
por: Holman, R, et al.
Publicado em: (1977)